← Leaderboards
Matthew J Pollman
Morehouse School Of Medicine
$654,361
Attributed
$654,361
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$654,361 · 4
By mechanism
K08$346,761 · 1
R01$307,600 · 1
P20$0 · 1
S06$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Morehouse School Of Medicine
Same institution · by research overlap
- Methode Bacanamwo$1,772,705
- David E Potter$2,153,728
- Mohamed A. Bayorh$1,775,621
- Kelwyn H Thomas$655,621
- Ruben Rene Gonzalez-Perez$1,703,200
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureVascular Smooth MuscleApoptosisLaboratory MouseAngiogenesisProtein KinaseBcl2 Gene /ProteinPhosphatidylinositol 3 KinaseTranscription FactorTransforming Growth FactorsFunctional /Structural GenomicsGel ElectrophoresisGene ExpressionGene MutationGenetically Modified AnimalsGrowth Factor ReceptorsHypertensionHypertrophyImmunocytochemistryJun KinaseMitogen Activated Protein KinaseMolecular PathologyNorthern BlottingsNucleic Acid Probes
Grant awards (6)
Role of Notch3 Signaling in Hypertensive Arteriopathy$307,600
R01 · FY2004 · HL
CELLULAR MEDIATORS OF VASCULAR CELL APOPTOSIS$115,587
K08 · FY2002 · HL
CORE--GENOMICS AND PROTEOMICS$0
P20 · FY2002 · MD
Vascular Cell Apoptosis: Mediator Role of Transforming Growth Factor-beta-1$0
S06 · FY2002 · GM
CELLULAR MEDIATORS OF VASCULAR CELL APOPTOSIS$115,587
K08 · FY2001 · HL
CELLULAR MEDIATORS OF VASCULAR CELL APOPTOSIS$115,587
K08 · FY2000 · HL